Antitrust

When companies collude to fix prices and restrain trade, harm accrues to competitors and individuals, alike. Antitrust lawsuits are used to stop practices that restrain trade and the operation of the free market and to compensate those who are harmed. The goal is to keep the market free, open, and competitive. Carella Byrne attorneys have significant experience and success litigating in this specialized area of the law, including:

  • In re: Liquid Aluminum Sulfate Antitrust Litigation, MDL No. 2687 (D.N.J.). Carella Byrne was appointed as Lead Counsel on behalf of direct purchasers of liquid aluminum sulfate for water treatment. The plaintiffs alleged that manufacturers of liquid aluminum sulfate conspired to stay away from each other’s customers by submitting high “throw away” bids that gave the appearance of competitive bidding. Carella Byrne and co-counsel for Plaintiffs worked hard to achieve settlements totaling more than $90,000,000.
Ongoing Litigation

Carella Byrne attorneys are currently litigating the following cases and would be happy to speak to you if you believe you might be impacted by these, or any other, antitrust matter. No question is too small. Please contact us today.

  • In re Vascepa Antitrust Litigation Indirect Purchaser Plaintiffs, No. 21-12061 (D.N.J.). Carella Byrne was appointed as one of the Interim Lead Counsel on behalf of indirect purchasers of Vascepa, a drug used to treat high cholesterol. The plaintiffs allege that the manufacturer of Vascepa, Amerin Pharmaceuticals, illegally maintained its monopoly for Vascepa by obtaining patents on the drug by fraud and, once generic versions of Vascepa were approved, by entering into exclusive agreements with all of the manufacturers of the active ingredients in Vascepa to prevent generic manufacturers from obtaining the necessary active ingredients for their own drugs.
  • In re Effexor XR Antitrust Litigation, No. 11-5661 (D.N.J.). Carella Byrne was appointed as Chair of Plaintiffs’ Indirect Purchaser Executive Committee. The plaintiffs allege that Teva and Wyeth entered into an illegal reverse-payment settlement agreement, which resulted in delays for the introduction of generic versions of Effexor, which, in turn caused patients and third-party payors to pay more for Effexor than they otherwise would have.

RELATED PRACTICES

Area of FOCUS

Price Fixing
Restraint of Trade

Antitrust Attorneys

Associate
Associate
Associate
Associate
Of Counsel

OUR ATTORNEYS

Practice Areas

Wills & Estates

Our attorneys understands how critical it is that business owners prepare for retirement or unforeseen circumstances in a way that provides for their financial well-being and the continuity of their companies.

Litigation

When disputes arise, our seasoned litigators provide exceptional advocacy grounded in holistic strategies designed to achieve each client’s overall business, financial, and personal goals.

Land Use Law

When zoning and land use roadblocks stand in the way of your objectives for a real estate investment or development project, our attorneys have the knowledge and experience necessary to move you forward.

About us

Restaurant Brands
Carella Byrne has filed a securities fraud class action lawsuit in the United States District Court for the Southern District of Florida against Restaurant Brands International Inc. on behalf of those individuals who purchased or acquired common stock.
Johnson & Johnson
Carella Byrne Cecchi Olstein Brody & Agnello filed a consumer class action Thursday in New Jersey District Court against Johnson & Johnson over its Neutrogena aerosol sunscreen line.
Takata Corp.
A Florida federal judge granted final approval Monday to a $42 million settlement automakers Volkswagen and Audi reached to resolve multidistrict litigation over their alleged use of defective Takata Corp. air bags, as well as a $12.6 million attorney fee award from that total.